Navigation Links
Bayer Temporarily Suspends Global Trasylol(R) Marketing
Date:11/5/2007

ttp://www.bayerhealthcare.com/trasylol/en" target="_new">http://www.bayerhealthcare.com/trasylol/en, and the German BfArM, U.S. FDA and Health Canada have posted information on their respective web sites.

About Trasylol

Important Safety Considerations

Trasylol(R) administration may cause fatal anaphylactic or anaphylactoid reactions. Fatal reactions have occurred with an initial (test) dose as well as with any of the components of the dose regimen. Fatal reactions have also occurred in situations where the initial (test) dose was tolerated. The risk for anaphylactic or anaphylactoid reactions is increased among patients with prior aprotinin exposure and a history of any prior aprotinin exposure must be sought prior to Trasylol(R) administration. The risk for a fatal reaction appears to be greater upon re-exposure within 12 months of the most recent prior aprotinin exposure. Trasylol(R) should be administered only in operative settings where cardio-pulmonary bypass can be rapidly initiated. The benefit of Trasylol(R) to patients undergoing primary CABG surgery should be weighed against the risk of anaphylaxis associated with any subsequent exposure to aprotinin.

(See CONTRAINDICATIONS, WARNINGS and PRECAUTIONS in the prescribing

information.)

Safety Considerations

Trasylol is contraindicated in patients with a known or suspected aprotinin exposure during the last 12 months. Aprotinin may also be a component of some fibrin sealant products.

-- In clinical studies, hypersensitivity and anaphylactic reactions were

rare (<0.1%) in patients with no prior exposure to Trasylol.

Trasylol administration increases the risk for renal dysfunction and may increase the need for dialysis in the perioperative period.

-- This risk may be especially increased for patients with pre-existing

renal impairment or those who receive aminoglycoside antibiotics or

drugs that al
'/>"/>

SOURCE Bayer HealthCare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
8. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
9. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
10. Briefing on a new Web resource to address global drinking water crisis
11. MDS Pharma Services Wins Award for Management of Global Malaria Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... -- Seeking to make it tougher for people to ... on Thursday approved a new hydrocodone tablet that,s designed ... by the brand name Vicodin -- is a powerful ... in dangerous addictions across the United States. The ... is an extended-release tablet to treat pain severe enough ...
(Date:11/21/2014)... they,ve mapped the genome -- the genetic "blueprint" -- of ... it might help others with this very rare infection. ... , the tapeworm was removed from the brain of a ... so rare worldwide and completely unexpected in this country that ... pulled out from the brain," study lead author Hayley Bennett, ...
(Date:11/21/2014)... November 21, 2014 Center for Autism ... titled “Massachusetts Insurance Funding for Autism Workshops” to help ... their way through the insurance coverage process. Parents ... law and the most effective ways to access coverage. ... 4 from 6-8:00 p.m. at 331 Montvale Ave., 5th ...
(Date:11/21/2014)... 21, 2014 Big Bud Farms announced ... episode of Innovations with Ed Begley Jr., airing via ... TBA. , Big Bud Farms, growers of legal medical ... and utilization of medical marijuana. , This segment of ... wide variety of products for medicating. Viewers will learn ...
(Date:11/21/2014)... 2014 Launched today on the iTunes ... all-in-one senior care coordination tool designed to make tracking ... and intuitive for family members and caregivers (e.g. physicians ... the family caregiver or home health aide providing care ... data, medical records, goals, schedules, and even final plans ...
Breaking Medicine News(10 mins):Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Comprehensive Senior Care Application Launched on Apple App Store 2
... LOS ANGELES, Nov. 8 Response Genetics, Inc.,(Nasdaq: ... development of molecular,diagnostic tests for cancer, today announced ... financial results in a press release on,Wednesday, November ... Response Genetics, Inc. ("RGI") is engaged in the ...
... EMPLOYERS(R) (NYSE: EIG ),a leading ... a,new partnership with the California Restaurant Association ... compensation insurance with a,special CRA membership discount. ... http://www.newscom.com/cgi-bin/prnh/20061030/LAM128LOGO ) "We are enthusiastic ...
... 8 DATATRAK International,Inc. (Nasdaq: DATA ), a ... the clinical trials industry, today reported its,operating results for ... For the three months ended September 30, 2007, ... net loss of $(3,506,000), or $(0.26),per share on a ...
... Resources on Partnership to Develop Rapid Molecular ... Tests for Healthcare-Associated Infections -, SAN DIEGO, Nov. 8 ... informed the Company it no longer intends to,fund the companies, ... The companies expect to formally terminate the,collaboration in the coming ...
... Approve Sale of Nabi ... Biologics to Biotest, ... today announced its third quarter,financial results. The company recorded a net ... September 29, 2007, which included,$7.5 million, or $0.12 per share, of ...
... Hispanic youth report better dental health habits than their non-Hispanic ... researchers at Columbia University Mailman School of Public Health. ... the Journal of Health Care for the Poor and Underserved, ... community in America. , The study, a snapshot of more ...
Cached Medicine News:Health News:Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday, November 14, 2007 2Health News:California Restaurant Association Chooses EMPLOYERS(R) as its New Provider of Choice for Members' Workers' Compensation Insurance Needs 2Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 2Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 3Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 4Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 5Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 6Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 7Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 8Health News:3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration 2Health News:3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration 3Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 2Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 3Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 4Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 5Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 6Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 7Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 8Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 9Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 10Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 11Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 12Health News:Study of minority New York City youth finds unequal burden of poor dental health 2
(Date:11/21/2014)... 20, 2014  The acceptance of two abstracts ... Global Congress demonstrates continued interest in the Eclipse ... bowel control. One of the abstracts, presented by ... Chief of Urogynecology and Reconstructive Pelvic Surgery at ... for Best Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal ...
(Date:11/21/2014)... Nov. 20, 2014 Oxis International, Inc. (OXIS) (OXI.PA) ... election of Anthony J. Cataldo as Chief Executive ... Effective November 19, 2014, Ken Eaton resigned his ... of Directors of Oxis International, Inc. to pursue new opportunities. ... named Chief Executive Officer of Oxis International, Inc. Mr. Cataldo ...
(Date:11/18/2014)... , Nov. 18, 2014  NxStage ® ... a leading manufacturer of innovative dialysis products ... Streamline® Express dialyzer for the in-center, hemodialysis ... set, which is designed to reduce the amount ... reduce the number of touch point contamination sites.  ...
Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
... and fabric specialty drapes for ... Steri-Drape absorbent prevention fabric creates ... strike-through reducing the need for ... Pack, Op tape, Hand towels, ...
... The table top design takes into ... and creates a flexible working environment for ... the alphamaxx can be matched exactly to ... top slide capability creates superior access for ...
... DePuy Mitek is the Market leader ... With ORTHOCORD Suture, DePuy Mitek has developed ... arthroscopic and open shoulder repair. ORTHOCORD Suture ... suture on the market. Most importantly, ORTHOCORD ...
... Now you can ... tactile sensitivity of the ... Free surgical gloves on ... Free gloves provide the ...
Medicine Products: